BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Discontinued (World)
Roche (RHHBY) Provides Update On Gantenerumab Development Programme 12/19/2014
H. Lundbeck A/S (LUN.CO) Will Halt Studies Into Vampire Bat Saliva Drug 12/19/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Traders Wobble On Merck KGaA (MKGAF.PK) After Stimuvax Stop 9/12/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/20/2014
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/12/2013
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/4/2013
Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns 5/7/2013
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy 4/19/2013
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML 4/3/2013
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study 3/21/2013
Moberg Derma Discontinues Clinical Development of Limtop 3/11/2013
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug 2/13/2013
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor 12/3/2012
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects 11/7/2012
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt 10/12/2012
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study 10/11/2012
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic 10/8/2012
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial 10/3/2012
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug 10/2/2012
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems 9/17/2012
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug 9/10/2012
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss 8/27/2012
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped 6/5/2012
Q-Med AB Discontinues the Breast Indication for Macrolane 4/17/2012
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox 12/5/2011
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study 11/29/2011
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer 11/28/2011
Moberg Derma Discontinues Preclinical Development Program for A-Fizz 10/27/2011
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug 10/10/2011
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug 9/29/2011
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program 8/8/2011
BeiLu Pharma Gives Up on Melatonin-based Depression Drug 7/19/2011
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab 6/28/2011
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product 6/24/2011
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine 5/5/2011
AstraZeneca PLC (AZN) Pulls Bloodthinner In France 3/24/2011
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries 2/15/2011
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations 12/15/2010
Roche (RHHBY) and Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Decision to Discontinue Phase 3 Ocrelizumab Clinical Development Program in Patients with Rheumatoid Arthritis 5/19/2010
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15% 4/29/2009
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound 11/17/2008
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts 10/8/2008
Life Science Weekly inSite (Sep. 29 - Oct. 3) 10/6/2008
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer 7/16/2008